Redefining Early Stage Investments (RESI)

Name: Redefining Early Stage Investments (RESI)
Start: 2022-11-15T08:00:00-05:00
End: 2022-11-16T17:00:00-05:00

15 November 2022 @ 8:00 am - 16 November 2022 @ 5:00 pm

RESI is the hot spot for the early-stage life science companies (Drugs, Devices, Diagnostics, and Digital Health, and raising Seed to Series B under $50M USD) to begin meeting investors and strategic partners who may eventually become a part of current or future capital raises.

Digital RESI November (15-16th): 2 days of digital partnering using the Partnering Platform. Expecting 250+ global investors and strategic partners.

BIOTECanada members receive 50% off standard registration. Join our Tech Hub today! To obtain your discount code email us: shaely.williams@biotech.ca

The majority of BIOTECanada’s over 200 member companies are small/medium sized, early-mid stage companies focused on the commercialization of an innovation.

Recognizing this, a core BIOTECanada strategic objective is to support member companies in successfully commercializing their business undertakings. In this context, BIOTECanada negotiates significant savings for member companies attending key industry investor/ partnering conferences including BIO, World Congress, Biotech Showcase and many others.

These offerings are designed to significantly reduce the cost of doing business for BIOTECanada members.

Click here to log in and visit the members only area

Access Codes

Don’t have access to the members only area?